TERF2IP expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.916600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.700200E-01
Normal-vs-Stage2
2.345600E-01
Normal-vs-Stage3
1.639240E-01
Normal-vs-Stage4
9.586600E-01
Stage1-vs-Stage2
1.887040E-01
Stage1-vs-Stage3
1.619150E-01
Stage1-vs-Stage4
6.024000E-01
Stage2-vs-Stage3
4.246000E-01
Stage2-vs-Stage4
1.996810E-01
Stage3-vs-Stage4
1.650040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.364600E-01
Normal-vs-AfricanAmerican
4.007000E-01
Normal-vs-Asian
1.289990E-01
Caucasian-vs-AfricanAmerican
4.974200E-01
Caucasian-vs-Asian
3.601600E-02
AfricanAmerican-vs-Asian
2.600800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.161200E-01
Normal-vs-Female
7.604200E-01
Male-vs-Female
9.564800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.909800E-01
Normal-vs-Age(41-60Yrs)
9.375800E-01
Normal-vs-Age(61-80Yrs)
7.731200E-01
Normal-vs-Age(81-100Yrs)
8.118000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.731000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.600600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.641000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.380800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.840300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.408750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.239180E-01
Normal-vs-Daily Drinker
3.189800E-01
Normal-vs-Weekly Drinker
1.332370E-01
Normal-vs-Occasional Drinker
7.788400E-01
Normal-vs-Social Drinker
7.211400E-01
Non Drinker-vs-Daily Drinker
3.609000E-01
Non Drinker-vs-Weekly Drinker
7.861000E-01
Non Drinker-vs-Occasional Drinker
8.341800E-02
Non Drinker-vs-Social Drinker
2.456200E-01
Daily Drinker-vs-Weekly Drinker
3.337800E-01
Daily Drinker-vs-Occasional Drinker
1.530170E-01
Daily Drinker-vs-Social Drinker
5.133400E-01
Weekly Drinker-vs-Occasional Drinker
7.436300E-02
Weekly Drinker-vs-Social Drinker
2.214000E-01
Occasional Drinker-vs-Social Drinker
3.106600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.291600E-01
Normal-vs-Grade 2
3.168200E-02
Normal-vs-Grade 3
4.519900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.986000E-02
Grade 1-vs-Grade 3
5.544100E-02
Grade 1-vs-Grade 4
3.291600E-01
Grade 2-vs-Grade 3
4.156600E-01
Grade 2-vs-Grade 4
3.168200E-02
Grade 3-vs-Grade 4
4.519900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.695400E-01
Normal-vs-NonDiabetic
8.368600E-01
Diabetic-vs-NonDiabetic
4.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.019700E-02
Normal-vs-NoPancreatitis
8.374800E-01
Pancreatitis-vs-NoPancreatitis
4.289600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.594000E-01
Normal-vs-N1
2.650000E-01
N0-vs-N1
4.408300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.944400E-02
Normal-vs-TP53-NonMutant
9.072000E-01
TP53-Mutant-vs-TP53-NonMutant
7.116400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
